Drug Regulatory Authority Pakistan (DRAP) has mandated eAPP software integration with its track and trace system, requiring all pharmaceutical companies to verify product and licence data by August 25 or face automatic portal lockdown.
By Imran Malik | Health & Business Desk | MediaBites.com.pk Report Courtesy: Umaid Ali
Pakistan’s pharmaceutical industry is facing one of its most significant regulatory deadlines in years. The Drug Regulatory Authority of Pakistan (DRAP) has announced the integration of its Track and Trace System with the eAPP software platform, in a move that authorities say will eliminate counterfeit medicines, end black market drug sales, and bring Pakistan’s pharmaceutical sector into full digital compliance.
The deadline is firm. August 25, 2026.
After that date, the eAPP portal will automatically lock. No data changes, corrections, or amendments will be accepted. Any pharmaceutical company that has not verified its product and licence data by then will find itself locked out of the system with no recourse.
What the New System Does
The integration of the Track and Trace System with eAPP represents a fundamental shift in how Pakistan’s pharmaceutical supply chain is monitored and regulated.
Under the new system, manual data entry has been completely eliminated. All information will be transferred automatically between systems, removing the human element that previously allowed fraudulent registrations, licence manipulations, and data tampering to occur.
Every medicine manufactured in Pakistan will be assigned a 2D barcode and serialisation code that tracks its movement from the factory floor to the pharmacy shelf. Every step of that journey, from manufacturing to wholesale to retail, will be recorded, timestamped, and visible to regulatory authorities in real time.
For the first time in Pakistan’s pharmaceutical history, patients and consumers will be able to independently verify the authenticity of any medicine they purchase by scanning the barcode with a smartphone, before taking it.
Why This Matters for Pakistan’s Pharmaceutical Industry
Pakistan’s pharmaceutical sector is estimated to be worth over PKR 600 billion annually and is one of the country’s most significant industrial sectors. It is also one where counterfeit and substandard medicines have been a persistent and deadly problem.
Counterfeit medicines are not simply an economic crime. They kill. Patients who believe they are taking genuine medication may be consuming sugar pills, diluted active ingredients, or in some cases harmful substitutes. Pakistan has seen multiple documented cases of patient harm and death linked to substandard pharmaceutical products reaching the market.
DRAP authorities say the Track and Trace integration will make the sale of counterfeit medicines effectively impossible. A medicine without a valid 2D barcode and serialisation cannot be verified as genuine and will be immediately identifiable as counterfeit at every point in the supply chain.
The elimination of manual data entry also directly addresses another persistent problem, fraudulent drug registrations and licence manipulation. When all data transfers automatically between verified systems, the opportunity for human intervention in the registration and licensing process disappears entirely.
The August 25 Deadline, What Companies Must Do
Pharmaceutical companies have until August 25, 2026 to complete the following steps through the eAPP portal.
Verify all product data currently registered in the system. Verify all licence data associated with their manufacturing and distribution activities. Ensure all information matches the requirements of the new Track and Trace integration framework.
After August 25, the portal locks automatically. No exceptions, no extensions, no data amendment requests accepted. DRAP authorities have described the deadline as absolute.
For Pakistan’s pharmaceutical industry, this is not a suggestion or a phased rollout with flexibility. It is a hard regulatory deadline with immediate and automatic consequences for non-compliance.
The Bigger Picture, Full Pharma Digitisation
DRAP authorities described the Track and Trace integration as a foundational step toward the complete digitalisation of Pakistan’s pharmaceutical industry. The goal, they said, is to eliminate fraudulent registrations, end black market medicine sales, and ensure that every patient in Pakistan receives genuine, quality-assured medication every time they visit a pharmacy.
For an industry that touches the lives of every Pakistani citizen, that goal is as important as any regulatory initiative Pakistan has undertaken in recent years.
2 Comments
Nếu đang tìm hiểu về fly888, bạn nên tham khảo thông tin từ nhiều nguồn để có góc nhìn đầy đủ.
fahzaenterprise enterprise solutions fahzaenterprise enterprise solutions fahzaenterprise enterprisesolutions enterprise solutions solutions